Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia
Open Access
- 9 February 2011
- journal article
- research article
- Published by Springer Nature in BMC Psychiatry
- Vol. 11 (1) , 23
Abstract
To identify a simple decision tree using early symptom change to predict response to atypical antipsychotic therapy in patients with (Diagnostic and Statistical Manual, Fourth Edition, Text Revised) chronic schizophrenia. Data were pooled from moderately to severely ill patients (n = 1494) from 6 randomized, double-blind trials (N = 2543). Response was defined as a ≥30% reduction in Positive and Negative Syndrome Scale (PANSS) Total score by Week 8 of treatment. Analyzed predictors were change in individual PANSS items at Weeks 1 and 2. A decision tree was constructed using classification and regression tree (CART) analysis to identify predictors that most effectively differentiated responders from non-responders. A 2-branch, 6-item decision tree was created, producing 3 distinct groups. First branch criterion was a 2-point score decrease in at least 2 of 5 PANSS positive items (Week 2). Second branch criterion was a 2-point score decrease in the PANSS excitement item (Week 2). "Likely responders" met the first branch criteria; "likely non-responders" did not meet first or second criterion; "not predictable" patients did not meet the first but did meet the second criterion. Using this approach, response to treatment could be predicted in most patients (92%) with high positive predictive value (79%) and high negative predictive value (75%). Predictive findings were confirmed through analysis of data from 2 independent trials. Using a data-driven approach, we identified decision rules using early change in the scores of selected PANSS items to accurately predict longer-term treatment response or non-response to atypical antipsychotic therapy. This could lead to development of a simple quantitative evaluation tool to help guide early treatment decisions. This is a retrospective, non-intervention study in which pooled results from 6 previously published reports were analyzed; thus, clinical trial registration is not required.Keywords
This publication has 23 references indexed in Scilit:
- Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of SchizophreniaNeuropsychopharmacology, 2009
- The Temporal Relationship Between Symptom Change and Treatment Discontinuation in a Pooled Analysis of 4 Schizophrenia TrialsJournal of Clinical Psychopharmacology, 2008
- Standard and Higher Dose of Olanzapine in Patients With Schizophrenia or Schizoaffective DisorderJournal of Clinical Psychopharmacology, 2008
- Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia☆Schizophrenia Research, 2008
- Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophreniaBMC Psychiatry, 2008
- Clinical, Functional, and Economic Ramifications of Early Nonresponse to Antipsychotics in the Naturalistic Treatment of SchizophreniaSchizophrenia Bulletin, 2007
- One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophreniaSchizophrenia Research, 2006
- Evidence for Onset of Antipsychotic Effects Within the First 24 Hours of TreatmentAmerican Journal of Psychiatry, 2005
- Early Prediction of Antipsychotic Response in SchizophreniaAmerican Journal of Psychiatry, 2003
- THE BRIEF PSYCHIATRIC RATING SCALEPsychological Reports, 1962